Company profile
MOMM Diagnostics GmbH
MOMM Diagnostics is developing préXclude, a revolutionary rapid preeclampsia test – the quickest and most accurate way to detect preeclampsia in pregnant women. Our test delivers results in just minutes, making it ideal for use in hospitals, clinics, and even at home. Preeclampsia is a serious and potentially life-threatening condition that affects up to 8% of pregnancies. With our test, early detection is possible, allowing for prompt medical intervention and better outcomes for both mother and baby.
Source: startup.ch
Highlights
Innosuisse Certificate
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
